Mutations in the SARS-CoV-2 spike receptor binding domain and their delicate balance between ACE2 affinity and antibody evasion
Protein & Cell · 2024
DOI: 10.1093/procel/pwae007 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Protein & Cell, 2024. Verfasst von Song Xue und 3 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Frontiers Science Cen…. Hauptthemen laut MEDLINE: Spike Glycoprotein, Coronavirus, Angiotensin-Converting Enzyme 2, SARS-CoV-2, Immune Evasion. Die Arbeit wurde bisher 80-mal zitiert (Crossref) und nennt 133 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program, National Natural Science Foundation of China, Shanghai Municipal Science and Technology Major Project.
Abstract (Originalsprache)
Intensive selection pressure constrains the evolutionary trajectory of SARS-CoV-2 genomes and results in various novel variants with distinct mutation profiles. Point mutations, particularly those within the receptor binding domain (RBD) of SARS-CoV-2 spike (S) protein, lead to the functional alteration in both receptor engagement and monoclonal antibody (mAb) recognition. Here, we review the data of the RBD point mutations possessed by major SARS-CoV-2 variants and discuss their individual effects on ACE2 affinity and immune evasion. Many single amino acid substitutions within RBD epitopes crucial for the antibody evasion capacity may conversely weaken ACE2 binding affinity. However, this weakened effect could be largely compensated by specific epistatic mutations, such as N501Y, thus maintaining the overall ACE2 affinity for the spike protein of all major variants. The predominant direction of SARS-CoV-2 evolution lies neither in promoting ACE2 affinity nor evading mAb neutralization but in maintaining a delicate balance between these two dimensions. Together, this review interprets how RBD mutations efficiently resist antibody neutralization and meanwhile how the affinity between ACE2 and spike protein is maintained, emphasizing the significance of comprehensive assessment of spike mutations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Frontiers Science Center of Pathogenic Microorganisms and Infection, School of Basic Medica…
Förderung
- National Key Research and Development Program
- National Natural Science Foundation of China
- Shanghai Municipal Science and Technology Major Project
- Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences
Zitieren
APA
Xue, S., Han, Y., Wu, F., & Wang, Q. (2024). Mutations in the SARS-CoV-2 spike receptor binding domain and their delicate balance between ACE2 affinity and antibody evasion. Protein & Cell. https://doi.org/10.1093/procel/pwae007
Vancouver
Xue S, Han Y, Wu F, Wang Q. Mutations in the SARS-CoV-2 spike receptor binding domain and their delicate balance between ACE2 affinity and antibody evasion. Protein & Cell. 2024. doi:10.1093/procel/pwae007
BibTeX
@article{Xue2024,
author = {Xue, Song and Han, Yuru and Wu, Fan and Wang, Qiao},
title = {Mutations in the SARS-CoV-2 spike receptor binding domain and their delicate balance between ACE2 affinity and antibody evasion},
journal = {Protein & Cell},
year = {2024},
doi = {10.1093/procel/pwae007}
}
EUVIMED